LEVERKUSEN, Germany and BOSTON and NEW YORK and TORONTO and KYOTO, Japan, Dec. 12, 2016 /PRNewswire/ — Bayer AG and Versant Ventures today announced the launch of BlueRock Therapeutics, a next-generation regenerative medicine company that plans to develop best-in-class induced pluripotent stem cell (iPSC) therapies to cure a range of …
Tag Archives: cardiovascular diseases
December, 2016
April, 2015
-
6 April
Bristol-Myers Squibb Enters Gene Therapy Deal with uniQure
Today, Bristol-Myers Squibb (BMS) announced that it has entered into a deal with uniQure for its gene therapy technology platform. The companies said that they have entered into an agreement that provides BMS with exclusive access to uniQure’s technology platform for multiple targets in cardiovascular diseases, as well as the …